SAFETY OVERVIEW: Most common side effects are gastrointestinal nausea, vomiting, diarrhoea, and reduced appetite typically occurring at treatment initiation and improving over time
Research continues to explore how peptides like GHK-Cu and compounds like cycloastragenol may support collagen production, cellular repair, and pathways involved in skin aging
Bruxism and Jaw Discomfort Some patients report increased stress, sleep disturbances, or anxiety while adjusting to weight loss medications
By activating both incretin pathways simultaneously, tirzepatide promotes satiety, slows gastric emptying, enhances insulin signalling, and appears to independently influence adipose tissue metabolism, producing effects on body weight and glucose handling that have consistently outperformed single-receptor approaches in published studies
Patients who tolerate GLP-1 therapy well and are being managed within a structured clinical programme